Sentiment · BMY
Lobbying Spend for BMY
AI-generated plain-English read of lobbying spend for BMY. Updated daily.
Heavy lobbying, holding steady
highHeavy but steady spend: a well-established government-affairs operation running at cruise control. DC risk is a recurring input to fundamentals for this issuer.
What will probably happen
- Stable spend means no new urgency. Existing policy relationships are being maintained; no imminent legislative inflection is signaled.
- Spend is spread across many issue areas: the company has diverse regulatory exposure and is fighting on multiple fronts simultaneously.
What to do
- If you HOLD this stock
- Stable, heavy DC presence is table stakes for this company. No new action triggered. Hold your thesis.
- If you're EVALUATING this stock
- Heavy DC presence is a recurring cost and risk factor. Factor in the regulatory environment when sizing. Requires research into the primary issue areas.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
15 quarters of history with $35.43M in total spend: sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Heavy
- Trajectory
- Stable
- Last quarter
- $3.63M
- Last 4Q total
- $10.63M
- Prior 4Q total
- $10.29M
- Top issue area
- HEALTH ISSUES (38% of spend)
- Top registrant
- BRISTOL-MYERS SQUIBB COMPANY (90% of spend)
- Registrant base
- In house
- Quarters on record
- 15
- Unique issue areas
- 9
- Unique registrants
- 12
- Issue concentration
- Broad
Key levels
| Level | Value |
|---|---|
| total amount | 35,430,000 |
| last 4q total | 10,630,000 |
| top issue pct | 0.38 |
| prior 4q total | 10,290,000 |
| top registrant pct | 0.897 |
| last quarter amount | 3,630,000 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.